HSIC · NASDAQ · Medical - Distribution

Henry Schein (HSIC)

Distributes clinical supplies and equipment alongside specialty products and practice software.

$86.12
vs last close−1.31 (−1.50%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue3,1623,0173,1723,1363,1743,1913,1683,2403,3393,4373,3683,458
Cost of revenue2,2262,1502,2212,1812,2452,2612,2302,2882,3812,4432,2982,357
Gross profit9368679519559299309389529589941,0701,101
725807791781724738736777752808888901
Selling, general & administrative725807791781724738736777752808809831
Other expenses00000000007970
Operating income21160160174205192202175206186182200
−29−42−30−36−74−65−54−50−69−51−32−64
Interest income655676699978
Interest expense252930323435353838393943
Other non-operating income717310433122163112−720
Income before tax18218130138131127148125137135150136
Income tax expense39132333231353128323834
Net income from continuing operations1431798105999611394109103112102
Net income137189310499941108610110110794
EPS, basic$1.05$0.14$0.72$0.81$0.79$0.75$0.89$0.71$0.84$0.86$0.93$0.83
EPS, diluted$1.05$0.14$0.72$0.80$0.78$0.74$0.88$0.70$0.84$0.85$0.92$0.82
Weighted average shares, basic130130129128126125124122120117115113
Weighted average shares, diluted131131130129127126125123121118116114
EBITDA273111230238236237253235255256256264
Depreciation & amortization696873747476737680826784
EBIT20443157164162161180159175174189180